Close X
Monday, November 11, 2024
ADVT 
National

EU regulator advises AstraZeneca's COVID drug be cleared

Darpan News Desk The Canadian Press, 24 Mar, 2022 12:41 PM
  • EU regulator advises AstraZeneca's COVID drug be cleared

LONDON (AP) — The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

The European Medicines Agency said in a statement that it was advising the use of the new drug, sold as Evusheld, in people age 12 and over before they were exposed to COVID-19, to prevent future infections.

It is now up to the EU's executive arm, the European Commission, to officially authorize the drug.

The U.S. Food and Drug Administration cleared the medication in December for people with serious health problems or allergies who can’t get adequate protection from vaccination. Britain authorized the use of Evusheld last week.

“When the antibodies in Evusheld attach to the spike protein, the virus cannot enter the cells to multiply and is unable to cause COVID-19 infection,” the EMA said. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated to last at least six months.

EMA said the drug's side effects were mostly mild, with some people reporting reactions at the injection point. The agency noted that research was done before the emergence of the hugely infectious omicron variant and said that it was evaluating data to determine if a different dose might be needed.

Although antibody drugs have been a standard treatment for treating COVID-19 infections for more than a year, AstraZeneca's is the first intended for long-term prevention against COVID-19 infection rather than as a short-term treatment.

People who could benefit from the antibody drug include cancer patients, organ transplant recipients and individuals taking immune-suppressing drugs for conditions like rheumatoid arthritis.

___

 

MORE National ARTICLES

Burnaby RCMP seizes about $100,000 worth of contraband cigarettes from Surrey home

Burnaby RCMP seizes about $100,000 worth of contraband cigarettes from Surrey home
Between December 25, 2021 and January 3, 2022, three businesses in industrial areas of Burnaby were broken into. Burnaby’s POST took conduct of the investigation and, with the assistance of local policing partners, were able to link the three break-ins and identify two suspects.

Burnaby RCMP seizes about $100,000 worth of contraband cigarettes from Surrey home

Canada, U.S. launch talks on data-sharing deal

Canada, U.S. launch talks on data-sharing deal
Today's announcement is part of a cross-border crime forum taking place this week in the U.S. capital with Public Safety Minister Marco Mendicino and Justice Minister David Lametti.    

Canada, U.S. launch talks on data-sharing deal

Liberal-NDP deal 'political theatre': expert

Liberal-NDP deal 'political theatre': expert
The deal says NDP MPs will side with the Liberals on key votes until 2025 — meaning they won’t bring down the government over the coming budget, for example, which is expected to be released in the next few weeks.

Liberal-NDP deal 'political theatre': expert

Contentious Kenney leadership vote now a mail-in

Contentious Kenney leadership vote now a mail-in
UCP president Cynthia Moore, in a public statement, says the change was due to the unexpected crush of people signing up to vote in Red Deer to decide whether Kenney should stay on as party leader.

Contentious Kenney leadership vote now a mail-in

Trudeau calls on EU to further aid Ukraine

Trudeau calls on EU to further aid Ukraine
Speaking to European parliamentarians this afternoon, the prime minister says those economic uncertainties have percolated for years, but are now stoked by rising global inflation.

Trudeau calls on EU to further aid Ukraine

NDP expect phased in approach to pharmacare

NDP expect phased in approach to pharmacare
The Liberals have promised in their new confidence and supply agreement with the NDP that they will pass a Canada Pharmacare Act by the end of next year.

NDP expect phased in approach to pharmacare